Vertex shares fell in after-hours trading, as investors considered a stock trading near its all-time high with a longer wait ...

Charles Lieber, the former chair of Harvard’s chemistry department who was convicted of lying to federal agents about his ...

Bristol Myers Squibb CEO warns against “slashing U.S. investment in medicines or importing lackluster policies of less ...

The European Commission unveiled a $565 million package to retain and attract scientists, as other countries try to leverage ...

An unexpected disclosure rocked the health insurance world last week: CVS Health decided it was pulling out of the Affordable ...

From STAT’s Adam Feuerstein: The FDA informed Capricor Therapeutics that a meeting of outside experts will be convened to ...

Some 100,000 people die from snakebites each year, largely in the developing world, while up to 400,000 suffer amputations or ...

The FDA is asking some of its recently fired staff responsible for critically important funding negotiations with drugmakers ...

Millipore Sigma, one of the largest suppliers of medical research products, will start adding a temporary tariff surcharge to ...

Cuts to the health insurance program are on the table as GOP lawmakers look for ways to pay for President Trump's tax cuts.

Despite the immense potential of gene therapies, drugmakers have soured on the field. So an ambitious charity is trying to ...

Here are five experts to follow to get a handle on what MAHA’s food moves really mean for the future of health.